KemPharm, Inc. (KMPH) insider have most recently took part in a trading activity. On Nov 27, 2017 Cohen Daniel L, EVP, Govt. & Public Relations bought 7,500 shares having total worth of $28,425 at the price of $3.79 per share, following the transaction a total of 31,250 shares owned by Cohen Daniel L. Before this latest buy, Cohen Daniel L purchased KMPH at 4 other times during the past twelve months, for a total investment of $51,875 at an average of $3.67 per share.
The stock has experienced a total of 1 insider trades in the past three months. These trades include 1 buy trades. Furthermore, over the past 12 months , the stock was traded 12 times by insiders. an employee of the company was the buyer in 12 instances.
|Time Frame||Number of Insider Buy||Number of Insider Sell||Stock Price Change(%)|
Shares of KemPharm, Inc. (KMPH) traded down 3.8% on Nov 28, 2017, hitting $3.63. 68,951 shares of the company’s stock traded hands. KemPharm, Inc. has a 52 week low of $2.55 and a 52 week high of $5.2. The company’s market cap is $65 million.
KemPharm, Inc. (KMPH) last announced its earnings results on Nov 9, 2017. The company reported -0.68 earnings per share (EPS) for the quarter, lower than the consensus estimate of -0.67 by $0.01. During the same quarter in the previous year, the company posted -0.92 earnings per share.
|earnings per share||-0.68||-0.44||-0.84||-0.68||-0.92||-0.58||0.12||-0.64||-0.68||-2.45|
Latest posts by William White (see all)
- Insider Trading Review: FS Investment Corporation $FSIC - January 13, 2018
- Insider Trader Watch: ENERTOPIA CORP $ENRT - January 13, 2018
- Insider Trading in Focus: Swiss Helvetia Fund, Inc. (The) $SWZ - January 13, 2018